Inactive Instrument
Sector Auspex Pharmaceuticals Inc
Stocks
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-04-22 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 15-04-22 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +4.98% | +5.73% | +3.13% | +63.51% | +85.30% | +54.45% | +113.83% | +10.21% | - | 70.88B | |
| -0.39% | +0.02% | -3.77% | +12.17% | +21.09% | +38.84% | +83.28% | +223.52% | +5,591.80% | 62.49B | |
| 0.00% | +7.68% | +9.05% | +72.41% | +68.58% | +32.24% | +24.27% | -56.02% | - | 26.34B | |
| +0.83% | -3.43% | -3.79% | +26.30% | -30.48% | -16.41% | +359.38% | +354.37% | +721.45% | 26.21B | |
| +2.02% | -0.87% | -15.93% | +7.82% | +2.94% | +1.85% | -7.92% | -71.29% | - | 24.13B | |
| 0.00% | +6.81% | +5.07% | +38.10% | +11.49% | +25.03% | -11.44% | -19.74% | +96.18% | 20.72B | |
| -2.54% | -3.36% | -17.86% | +20.35% | +171.42% | +149.64% | +324.48% | +1,371.57% | +639.24% | 15.69B | |
| -1.95% | +1.80% | +5.81% | +10.23% | +30.55% | +42.69% | +165.15% | +181.46% | +288.20% | 14.46B | |
| -5.32% | -8.25% | +28.42% | +22.91% | -3.37% | -10.53% | +823.50% | +160.80% | +116.67% | 14.24B | |
| 0.00% | +7.18% | -5.24% | +26.30% | +26.36% | -5.69% | +529.33% | - | - | 14.06B | |
| -1.80% | -3.35% | +1.01% | +3.21% | -10.37% | +18.65% | +227.23% | +565.43% | +4,585.46% | 12.28B | |
| -2.11% | +2.05% | +10.02% | +17.18% | -13.98% | -25.80% | +159.20% | +122.94% | - | 10.63B | |
| -1.77% | -6.75% | -12.08% | -14.24% | +6.33% | +38.84% | +116.26% | +105.54% | +663.39% | 9.56B | |
| +3.47% | -14.73% | -21.03% | -15.93% | +3.62% | +124.14% | +152.63% | +10.31% | +854.09% | 9.39B | |
| -0.35% | +0.96% | +8.47% | +14.81% | +326.77% | +209.52% | +416.82% | -14.73% | - | 8.99B | |
| +1.36% | -1.04% | -5.91% | +14.54% | +27.70% | +85.57% | +12.90% | +133.16% | - | 8.65B | |
| -1.18% | +5.10% | +6.87% | +18.80% | +10.14% | -23.75% | +96.04% | -22.63% | - | 8.04B | |
| +1.97% | +1.35% | -13.58% | +4.18% | +180.92% | +518.48% | +688.60% | -52.19% | -42.21% | 7.96B | |
| +1.43% | +0.23% | +7.66% | +18.67% | +8.40% | +147.01% | +493.84% | - | - | 6.88B | |
| Average | -0.07% | -0.87% | -0.72% | +19.02% | +48.60% | +73.94% | +250.91% | +176.63% | +1,351.43% | 18.58B | |
| Weighted average by Cap. | +0.68% | +0.96% | -0.51% | +28.28% | +44.97% | +51.31% | +188.61% | +161.38% | +2,365.60% |
- Stock Market
- Stocks
- Stock
- Sector Auspex Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
